Related Experiment Video
Updated: May 17, 2026

An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas
Published on: October 10, 2025
Rac1 is required for Prkar1a-mediated Nf2 suppression in Schwann cell tumors
P K Manchanda1, G N Jones, A A Lee
1Department of Molecular, Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, OH 43210, USA.
Rac1 signaling suppresses Nf2 protein, driving schwannoma tumor growth. Inhibiting Rac1 in a mouse model reduced tumors and restored Nf2, revealing a bidirectional relationship crucial for controlling cell growth.
Area of Science:
- Oncology
- Cell Biology
- Genetics
Background:
- Schwannomas are peripheral nerve sheath tumors often linked to genetic syndromes like neurofibromatosis.
- Loss of the NF2 tumor suppressor is associated with increased Rac1 activity, a key factor in tumor development.
Purpose of the Study:
- To investigate the role of Rac1 in schwannoma formation driven by Prkar1a deficiency.
- To elucidate the bidirectional signaling interplay between NF2 and Rac1 in Schwann cells.
Main Methods:
- Generated a double knockout (DKO) mouse model of Prkar1a and Rac1 in Schwann cells.
- Analyzed tumor formation, cell proliferation, apoptosis, and protein expression (NF2, Rac1, Pak).
- Performed in vitro experiments to assess Rac1's effect on NF2 regulation.
Main Results:
- Loss of Rac1 significantly reduced schwannoma formation by decreasing proliferation and increasing apoptosis.
- Simultaneously, Nf2 protein re-expression was observed in the DKO model.
- Activated Rac1 was found to downregulate Nf2 protein in a Pak-dependent manner in vitro.
Conclusions:
- Rac1 activation suppresses Nf2 protein production, leading to uncontrolled Schwann cell growth and schwannoma development.
- The PKA pathway, activated by Prkar1a mutations, initiates Rac1 signaling, subsequently reducing Nf2 and promoting tumorigenesis.
- Signaling between Nf2 and Rac1 is bidirectional and modulated by Protein Kinase A (PKA).
More Related Videos
08:57Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
09:33Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Ras Gene
Ras is a superfamily...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Abnormal Proliferation
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity: